{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:47Z","timestamp":1761919667473,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clinre.2012.10.013","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T02:46:13Z","timestamp":1356576373000},"page":"359-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs"],"prefix":"10.1016","volume":"37","author":[{"given":"Levent","family":"Doganay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyas","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyma","family":"Katrinli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feruze Yilmaz","family":"Enc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguzhan","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasar","family":"Colak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celal","family":"Ulasoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizem","family":"Dinler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2012.10.013_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2012.10.013_bib0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"727\u201359","key":"10.1016\/j.clinre.2012.10.013_bib0015","first-page":"vii","article-title":"The immunology of hepatitis B","volume":"11","author":"Vierling","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2012.10.013_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.icb.7100009","article-title":"Immunopathogenesis of hepatitis B virus infection","volume":"85","author":"Chang","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0025","series-title":"Liver Immunology: Principles and Practice","first-page":"179","article-title":"Role of the immune response in hepatitis B","author":"Bertoletti","year":"2005"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2012.10.013_bib0030","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0168-8278(03)00137-5","article-title":"Immunopathogenesis of hepatitis B","volume":"39","author":"Ferrari","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000282075","article-title":"Innate and adaptive immune responses in hepatitis B virus infection","volume":"28","author":"Das","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2012.10.013_bib0040","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/v2071394","article-title":"Innate antiviral immune responses to hepatitis B virus","volume":"2","author":"Ait-Goughoulte","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.clinre.2012.10.013_bib0045","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3748\/wjg.v13.i12.1770","article-title":"A comparative review of HLA associations with hepatitis B and C viral infections across global populations","volume":"13","author":"Singh","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0050","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM199504203321604","article-title":"Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia","volume":"332","author":"Thursz","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2012.10.013_bib0055","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3748\/wjg.v9.i10.2221","article-title":"Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B","volume":"9","author":"Jiang","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0060","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3748\/wjg.v11.i36.5721","article-title":"Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients","volume":"11","author":"Han","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5858\/2007-131-117-HLAAAH","article-title":"Human leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans","volume":"131","author":"Hwang","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clinre.2012.10.013_bib0070","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1128\/JVI.77.22.12083-12087.2003","article-title":"Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection","volume":"77","author":"Thio","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0075","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1086\/314684","article-title":"Class II HLA alleles and hepatitis B virus persistence in African Americans","volume":"179","author":"Thio","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinre.2012.10.013_bib0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","author":"Marcellin","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.10.013_bib0090","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1440-1746.2010.06271.x","article-title":"On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective","volume":"25","author":"Chien","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2012.10.013_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1478-3231.2010.02399.x","article-title":"Hepatitis B virus resistance to antiviral drugs: where are we going?","volume":"31","author":"Zoulim","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2012.10.013_bib0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0039.1993.tb01991.x","article-title":"HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2hours","volume":"41","author":"Olerup","year":"1993","journal-title":"Tissue Antigens"},{"issue":"869\u201392","key":"10.1016\/j.clinre.2012.10.013_bib0105","first-page":"ix","article-title":"Antiviral therapy of chronic hepatitis B: prevention of drug resistance","volume":"11","author":"Fournier","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2012.10.013_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1744-313X.2006.00607.x","article-title":"Analysis of HLA-DQB1 gene polymorphisms in asymptomatic HBV carriers and chronic hepatitis B patients in the Chinese Han population","volume":"33","author":"Xi-Lin","year":"2006","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.clinre.2012.10.013_bib0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jpeds.2005.12.025","article-title":"HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: a long-term prospective sibling cohort study in Taiwan","volume":"148","author":"Wu","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinre.2012.10.013_bib0120","first-page":"139","article-title":"Tissue types as prognostic risk factor in hepatitis B virus infection","volume":"21","author":"Akcam","year":"2002","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1399-0039.1997.tb02827.x","article-title":"Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination","volume":"50","author":"McDermott","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clinre.2012.10.013_bib0130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-0039.1998.tb03001.x","article-title":"Response to hepatitis B vaccine: multiple HLA genes are involved","volume":"51","author":"Desombere","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clinre.2012.10.013_bib0135","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hep.20614","article-title":"Acute phase HBV-specific T cell responses associated with HBV persistence after HBV\/HCV coinfection","volume":"41","author":"Urbani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.10.013_bib0140","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1440-1746.2008.05385.x","article-title":"Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective","volume":"23","author":"Tan","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2012.10.013_bib0145","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.clinre.2012.10.013_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2012.10.013_bib0155","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI3731","article-title":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B","volume":"102","author":"Boni","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2012.10.013_bib0160","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.21340","article-title":"Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV","volume":"44","author":"van der Molen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2012.10.013_bib0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2006.11.018","article-title":"Inhibition of viral replication reduces regulatory T-cells and enhances the antiviral immune response in chronic hepatitis B","volume":"361","author":"Stoop","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.clinre.2012.10.013_bib0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/AAC.00467-07","article-title":"Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+T-cell reactivity","volume":"52","author":"Cooksley","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740112003324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740112003324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:49Z","timestamp":1761895069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740112003324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2210740112003324"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2012.10.013","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2012.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}